Last news
Mérieux NutriSciences and AsureQuality Announce the Official Launch of Mérieux NutriSciences AQ (MNAQ) Joint Venture

Mérieux NutriSciences and AsureQuality Announce the Official Launch of Mérieux NutriSciences AQ (MNAQ) Joint Venture

CHICAGO and AUCKLAND, New Zealand, June 2, 2025 /PRNewswire/ -- Merieux NutriSciences, a global leader in food safety, quality, and sustainability, and AsureQuality, New Zealand's premier food assurance provider, are pleased to announce the official...

Xinhua Silk Road: 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament concludes with record participation

Xinhua Silk Road: 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament concludes with record participation

BEIJING, June 1, 2025 /PRNewswire/ -- The 21st Shanghai Suzhou Creek Dragon Boat Invitational Tournament wrapped up on May 25 in Putuo District of Shanghai, setting a new record for participation over the past decade. A total of 58 teams from...

China Liberal Education Holdings Limited Announces Suspension of Nasdaq Trading

China Liberal Education Holdings Limited Announces Suspension of Nasdaq Trading

BEIJING, June 1, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (Nasdaq: CLEU), a China-based company that provides technological consulting services for smart campus solutions and other educational...

Blokees made its debut at CCXP México 2025, Officially Enters México Market

Blokees made its debut at CCXP México 2025, Officially Enters México Market

SHANGHAI, June 1, 2025 /PRNewswire/ -- On May 30, 2025, the most influential pop culture exhibition in Latin America, CCXP Mexico 2025, grandly opened in Mexico. Chinese building block character toy brand Blokees brought multiple IP series products...

InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

InxMed Announces Promising Phase Ib/II Clinical Data for Ifebemtinib + KRAS G12C inhibitor in KRAS G12C-Mutant Solid Tumors at ASCO 2025

NANJING, China, June 1, 2025 /PRNewswire/ -- InxMed Co., Ltd, a clinical-stage biotechnological company, pioneering therapies to transform cancer treatment, released latest clinical data from a Phase Ib/II clinical trial (NCT06166836; NCT05379946)...

Tianfu Rapoil Shines at Hong Kong Hometown Market Carnival

Tianfu Rapoil Shines at Hong Kong Hometown Market Carnival

HONG KONG, June 1, 2025 /PRNewswire/ -- This is a report from Xinhuanet: Co-organized by 30 provincial-level hometown associations in Hong Kong, the "Third Hometown Market Carnival" was kicked off on June 1 in Victoria Park, marking the beginning of...

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma

ASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI363 (First-in-class PD-1/IL-2α -bias Bispecific Antibody Fusion Protein) from Phase 1 and 2 Clinical Studies on Immunotherapy-treated Advanced Malignant Melanoma

SAN FRANCISCO and SUZHOU, China, June 1, 2025 /PRNewswire/ -- Innovent Biologics, Inc (Suzhou) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...

Zeekr Group Announces May 2025 Delivery Update

Zeekr Group Announces May 2025 Delivery Update

HANGZHOU, China, June 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results for May 2025. In May,...

menu
menu